Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes - Wright, Alison K.; Carr, Matthew J.; Kontopantelis, Evangelos; Leelarathna, Lalantha; Thabit, Hood; Emsley, Richard; Buchan, Iain; Mamas, Mamas A.; van Staa, Tjeerd P.; Sattar, Naveed; Ashcroft, Darren M.; Rutter, Martin K. (Diabetes care, 2022)
Keywords: Agonists; Cardiovascular diseases; Cardiovascular Diseases - complications; Clinical trials; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - chemically induced; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Disease prevention; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucagon-Like Peptide-1 Receptor - agonists; Health care; Heart diseases; Heart failure; Heart Failure - epidemiology; Heart Failure - prevention & control; Humans; Hypoglycemic Agents - therapeutic use; Inhibitor drugs; Inhibitors; Patients; Primary care; Primary Prevention; Receptors; Research design; Sodium-glucose cotransporter; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use